Essential Pharma

Essential Pharma is a global specialty pharmaceutical company focused on developing and delivering high-quality medicines for patients in small, underserved, or rare disease populations. With a portfolio reaching approximately 70 countries, the company focuses on therapeutic areas including rare disease, CNS, ophthalmology, and gastroenterology, and is developing an anti-GD2 antibody for high-risk neuroblastoma. The company emphasizes corporate responsibility and ensuring access to essential medicines.

Essential Pharma has a presence in Spain, as evidenced by a current opening for a Key Account Manager Iberia. The company's culture is described as open to driven and passionate individuals from all backgrounds who share a commitment to making a difference for patients in niche populations. This makes it a potential employer for international professionals interested in the pharmaceutical industry in Spain.